Application of Transfer Learning for Biomedical Signals: A Comprehensive Review of the Last Decade (2014-2024)
Information Fusion,
Journal Year:
2025,
Volume and Issue:
118, P. 102982 - 102982
Published: Jan. 30, 2025
Language: Английский
Boruta Feature Selection and Deep Learning for Alzheimer’s Disease Classification
Ramu S. Siddaganga,
No information about this author
Nagaraj Naik,
No information about this author
H A Dinesha
No information about this author
et al.
International Journal of Statistics in Medical Research,
Journal Year:
2025,
Volume and Issue:
14, P. 145 - 152
Published: March 25, 2025
Alzheimer’s
Disease
(AD)
is
a
progressive
neurodegenerative
disorder
characterized
by
cognitive
decline,
memory
impairment,
and
functional
deterioration.
The
early
accurate
classification
of
AD
crucial
for
timely
intervention
management.
This
study
utilizes
the
Boruta
feature
selection
method
to
identify
most
relevant
features
classification,
selecting
top
15
based
on
importance
ranking.
Three
machine
learning
models—Deep
Neural
Networks
(DNN),
Long
Short-Term
Memory
(LSTM),
Support
Vector
Machines
(SVM)—were
evaluated
using
accuracy,
precision,
recall,
F1-score
as
performance
metrics.
LSTM
model
demonstrated
highest
accuracy
(89.30%),
outperforming
DNN
(88.14%)
SVM
(84.19%),
owing
its
capability
capturing
temporal
dependencies
in
inpatient
data.
Results
indicate
that
deep
models
offer
superior
compared
traditional
approaches
classification.
emphasizes
cognitive,
lifestyle,
metabolic
diagnosis
while
acknowledging
limitations
such
dataset
constraints
interpretability.
Future
research
should
improve
explainability,
incorporate
multi-modal
data,
leverage
real-time
monitoring
techniques
enhanced
detection.
Language: Английский
Harnessing Explainable Artificial Intelligence (XAI) based SHAPLEY Values and Ensemble Techniques for Accurate Alzheimer's Disease Diagnosis
R. Balakrishnan,
No information about this author
Manyam Rajasekhar Reddy,
No information about this author
Prasad Theeda
No information about this author
et al.
Engineering Technology & Applied Science Research,
Journal Year:
2025,
Volume and Issue:
15(2), P. 20743 - 20747
Published: April 3, 2025
Machine
Learning
(ML)
is
a
dynamic
method
for
managing
extensive
datasets
to
uncover
significant
patterns
and
hidden
insights.
ML
has
revolutionized
numerous
industries,
from
healthcare
finance,
entertainment
transportation.
Ensemble
classifiers
combined
with
Explainable
AI
(XAI)
have
surfaced
as
asset
in
the
field
of
Alzheimer's
Disease
(AD)
diagnosis.
Boosting
EC
techniques
coupled
Shapley
Additive
Explanations
(SHAP)
offers
powerful
approach
AD
This
paper
investigates
boosting
ensemble
schemes,
such
XGBoost,
LightGBM,
Gradient
(GB),
diagnosis
SHAP
feature
selection.
The
proposed
scheme
achieved
efficient
results,
an
accuracy
more
than
94%
minimum
features
detection
process.
Language: Английский
Hybrid of DSR-GAN and CNN for Alzheimer disease detection based on MRI images
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 13, 2025
In
this
paper,
we
propose
a
deep
super-resolution
generative
adversarial
network
(DSR-GAN)
combined
with
convolutional
neural
(CNN)
model
designed
to
classify
four
stages
of
Alzheimer's
disease
(AD):
Mild
Dementia
(MD),
Moderate
(MOD),
Non-Demented
(ND),
and
Very
(VMD).
The
proposed
DSR-GAN
is
implemented
using
PyTorch
library
uses
dataset
6,400
MRI
images.
A
(SR)
technique
applied
enhance
the
clarity
detail
images,
allowing
refine
particular
image
features.
CNN
undergoes
hyperparameter
optimization
incorporates
data
augmentation
strategies
maximize
its
efficiency.
normalized
error
matrix
area
under
ROC
curve
are
used
experimentally
evaluate
CNN's
performance
which
achieved
testing
accuracy
99.22%,
an
100%,
rate
0.0516.
Also,
assessed
three
different
metrics:
structural
similarity
index
measure
(SSIM),
peak
signal-to-noise
ratio
(PSNR),
multi-scale
(MS-SSIM).
SSIM
score
0.847,
while
PSNR
MS-SSIM
percentage
29.30
dB
96.39%,
respectively.
combination
models
provides
rapid
precise
method
distinguish
between
various
disease,
potentially
aiding
professionals
in
screening
AD
cases.
Language: Английский